Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pule

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
ACS Chemical Biology|January 20, 2024
Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein-Protein InteractionRam Jha, Alexander Kinna, Alastair Hotblack, et al.
Blood|December 30, 2017
An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myelomaLydia Lee, Benjamin Draper, Neil Chaplin, et al.
Frontiers in Immunology|June 19, 2023
Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2Julia Taylor, Anna Bulek, Isaac Gannon, et al.
Scientific Reports|November 10, 2021
Tunable control of CAR T cell activity through tetracycline mediated disruption of protein-protein interactionAlastair Hotblack, Evangelia K Kokalaki, Morgan J Palton, et al.
Blood|October 11, 2011
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaChrystal U Louis, Barbara Savoldo, Gianpietro Dotti, et al.
Journal of Virology|July 21, 2021
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 VariantsMathieu Ferrari, Leila Mekkaoui, F Tudor Ilca, et al.
Science Translational Medicine|April 16, 2025
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemiaNicola Maciocia, Malika Hoekx, Ciaran Acuna, et al.
Nature Medicine|July 5, 2023
Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemiaNathaniel D Anderson, Jack Birch, Theo Accogli, et al.
Cancer Research|July 18, 2015
Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell ImmunotherapiesLaurent Poirot, Brian Philip, Cécile Schiffer-Mannioui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4<sup>+</sup>PD-1<sup>+</sup> Cells and Inferior Survival in Patients with Newly Diagnosed Multiple MyelomaNouf Alrasheed, Lydia Lee, Ehsan Ghorani, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
ACS Chemical Biology|January 20, 2024
Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein-Protein InteractionRam Jha, Alexander Kinna, Alastair Hotblack, et al.
Blood|December 30, 2017
An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myelomaLydia Lee, Benjamin Draper, Neil Chaplin, et al.
Frontiers in Immunology|June 19, 2023
Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2Julia Taylor, Anna Bulek, Isaac Gannon, et al.
Scientific Reports|November 10, 2021
Tunable control of CAR T cell activity through tetracycline mediated disruption of protein-protein interactionAlastair Hotblack, Evangelia K Kokalaki, Morgan J Palton, et al.
Blood|October 11, 2011
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaChrystal U Louis, Barbara Savoldo, Gianpietro Dotti, et al.
Journal of Virology|July 21, 2021
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 VariantsMathieu Ferrari, Leila Mekkaoui, F Tudor Ilca, et al.
Science Translational Medicine|April 16, 2025
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemiaNicola Maciocia, Malika Hoekx, Ciaran Acuna, et al.
Nature Medicine|July 5, 2023
Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemiaNathaniel D Anderson, Jack Birch, Theo Accogli, et al.
Cancer Research|July 18, 2015
Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell ImmunotherapiesLaurent Poirot, Brian Philip, Cécile Schiffer-Mannioui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4<sup>+</sup>PD-1<sup>+</sup> Cells and Inferior Survival in Patients with Newly Diagnosed Multiple MyelomaNouf Alrasheed, Lydia Lee, Ehsan Ghorani, et al.
Pageof 8